Loading clinical trials...
Loading clinical trials...
Tumor Microenvironment Surveillance on Simultaneous Liver Metastases Extensive Stage Small Cell Lung Cancer Who Treated With Atezolizumab Plus Etoposide and Platinum Based Chemotherapy
The purpose of the trial is to detect tumor microenvironment on Extensive Stage Small Cell Lung Cancer with simultaneous liver metastases who Treated with Atezolizumab plus Etoposide and Platinum Based Chemotherapy.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hunan Cancer Hospital
Changsha, Hunan, China
Start Date
April 1, 2019
Primary Completion Date
July 1, 2021
Completion Date
September 1, 2021
Last Updated
January 25, 2022
60
ACTUAL participants
First line EC/EP+Atezolizumab
DRUG
Lead Sponsor
Hunan Province Tumor Hospital
NCT07037758
NCT05468489
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01999881